Tree of Knowledge International Corp. Enters 50 Million Pound UK CBD Market With Initial White Labeling Purchase Order of $50...
January 17 2019 - 9:00AM
via NEWMEDIAWIRE -- Tree of Knowledge International
Corp.
(CSE: TOKI; OTC
PINK: TRKWF
) (the
"
Company" or
"
CBD")
is pleased to
announce that CBD&CBN Ltd.
("
CBD&CBN")
a company
registered in the UK and headquartered in London, England is slated
to launch its white label of TOK’s brand in the UK through the
worldwide web. The CBD&CBN brand was developed pursuant to a
white label agreement between TOK and CBD&CBN dated November
19, 2018.
The Company’s strategy in the UK includes the premium product
line supplied for distribution under CBD&CBN’s brand. The
Company is prepared for success and current operations are capable
of a one week turn around on order fulfillment before packaging and
customs.
CBD&CBN is set to commence operations late
this month and has made its first purchase order of US$50,000 from
the Company. CBD&CBN operates under the direction of Stephen
Oliver, former HM Customs Investigator and lawyer, and Andy Eyre,
former military and entrepreneur, two individuals with a robust
combined industry history and skill set. In its initial phase
CBN&CBD is focused on generating exposure and building brand
recognition through a comprehensive e-commerce strategy.
CBD&CBN is supported by Mr. George Pessios, Software Engineer,
IOS Developer and Web Designer, and founding member CBD&CBN,
and Nick Gower, founding member and Search Engine Optimization
expert.
Jean-Paul Gaillard, CEO of the Company, commented:
“Their combined professional track record and wealth of knowledge
has laid a foundation for Tree of Knowledge’s aggressive strategy
to create a dominant presence in the rapidly evolving CBD sector in
the European Marketplace.”
Founded in 2015, the Company launched its EVR CBD
product line with the purpose of creating the finest quality CBD
Hemp Oil in the world. EVR CBD now sells CBD Hemp Oil to customers
throughout the US, Europe and South America, and sells isolates
into Australia. As additional territories follow the lead of the
United States and legalize CBD hemp oil, the Company expects that
additional consumers will discover its benefits. The Company
aspires to have its EVR CBD brand as the world’s most trusted
source for CBD products.
According to the Cannabis Trades Association UK,
the consumer base in the CBD market in the UK has doubled from
125,000 to 250,000 between 2017 and 2018. Currently in the UK, the
number of people using CBD oil is estimated to have reached around
300,000. According to Verdict.co.uk, an online media publisher:
“The rise in popularity has followed a loosening of legal
restrictions around the world. Although CBD-based products have
been commercially available in the UK for some time, they appear to
be gaining greater mainstream use and acceptance.” Reports by
Forbes indicate that the global cannabidiol (CBD) market is
estimated to grow by 700% and could be worth $2.1 billion by
2020.
ABOUT TREE OF KNOWLEDGE
With its head office in Toronto and operations in
North York, Ontario and Spokane, Washington, TOK currently has
three primary business segments: (1) Multidisciplinary specialty
pain clinics with a focus on the treatment of chronic pain,
including controlled applications of medical cannabis in Canada,
(2) Development of formulated products for therapeutic purposes and
natural health product alternatives at its manufacturing facility
in Spokane, which provides formulations for the Company’s products
and for third parties equivalent to GMP standards, and (3)
Distribution and sale of hemp-based cannabidiol (“CBD”) products in
the United States, Canada, Europe, Brazil and China. Through an
exclusive strategic alliance agreement with Jack Nathan Medical
Inc., which operates over 72 Jack Nathan Health medical and dental
clinics in six provinces across Canada, the Company has access to
one of the largest healthcare systems across Canada for its
education and research platform, with over 1.5 million patient
visits annually. Currently the Company has research agreements with
multiple universities for medical cannabis research and new medical
grade products development. TOK’s CBD product line contains EVR
Premium Hemp Oil, which is an organically grown and handled,
gluten-free, vegan, non-GMO, synergistic compound that is derived
from U.S. Department of Agriculture (USDA) approved industrial hemp
grown in the United States. TOK currently offers several CBD
products, which may be used in connection with the treatment of a
number of ailments and for general wellness purposes.
For further information please
visit: www.tok.ca
Or contact: Tree of Knowledge International
Corp.
Michael Caridi, Vice Chairman
Tel: +1 (917) 295-1374 Michael@tok.ca THE CSE
HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE
ACCURACY OR ADEQUACY OF THIS RELEASE.
Advisory
This news release contains forward-looking
statements relating to the benefits expected from the while label
arrangement with CBD&CBN Ltd. and the future operations of TOK
and other statements that are not historical facts. Forward-looking
statements are often identified by terms such as "will", "may",
"should", "anticipate", "expects" and similar expressions. All
statements other than statements of historical fact, included in
this release, including, without limitation, statements regarding
the future plans and objectives of TOK, are forward looking
statements that involve risks and uncertainties. There can be no
assurance that such statements will prove to be accurate and actual
results and future events could differ materially from those
anticipated in such statements. Important factors that could cause
actual results to differ materially from TOK's expectations are
risks detailed from time to time in the filings made by TOK with
securities regulations.
The reader is cautioned that assumptions used in
the preparation of any forward-looking information may prove to be
incorrect. Events or circumstances may cause actual results to
differ materially from those predicted, as a result of numerous
known and unknown risks, uncertainties, and other factors, many of
which are beyond the control of TOK. As a result, TOK cannot
guarantee that any forward-looking statement will materialize and
the reader is cautioned not to place undue reliance on any
forward-looking information. Such information, although considered
reasonable by management at the time of preparation, may prove to
be incorrect and actual results may differ materially from those
anticipated. Forward-looking statements contained in this news
release are expressly qualified by this cautionary statement. The
forward-looking statements contained in this news release are made
as of the date of this news release and TOK will update or revise
publicly any of the included forward-looking statements as
expressly required by Canadian securities law.
This news release contains market and industry
data that has been obtained from third party sources, including
industry publications. The Company believes that its industry data
is accurate and that its estimates and assumptions are reasonable,
but there is no assurance as to the accuracy or completeness of
this data. Third party sources generally state that the information
contained therein has been obtained from sources believed to be
reliable, but there is no assurance as to the accuracy or
completeness of included information. Although the data is believed
to be reliable, the Company has not independently verified any of
the data from third party sources referred to in this news release
or ascertained the underlying economic assumptions relied upon by
such sources.